io, what you posted wasn't the issue.
In response to the DD post wrt 2 small p drugs that got approved with difficulty, Y3 wrote
"your comment above reads that you concede Proellex will in fact be approved."
DD had clearly not conceded the point, his post did not state he did, so he told Y3 he was wrong.
How does the fact that the other drugs got to market change DD's opinion that Proellex might not?
You can debate the underlying issue all you wish, but the DD post cleary did not "read" as Y3 posted.
I still think DD could have given a better example. Satraplatin comes quickly to mind.
Market Data 
Markets 
AI
